Filing Details
- Accession Number:
- 0001179110-15-007535
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-11 17:04:32
- Reporting Period:
- 2015-05-07
- Filing Date:
- 2015-05-11
- Accepted Time:
- 2015-05-11 17:04:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1200493 | E Dorothy Puhy | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Disposition | 2015-05-07 | 2,611 | $70.00 | 70,617 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2015-05-07 | 403 | $70.81 | 70,214 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2015-05-07 | 260 | $71.85 | 69,954 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2015-05-07 | 128 | $73.00 | 69,826 | No | 4 | S | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2015-05-07 | 22 | $73.78 | 69,804 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $13.21 | 2007-08-08 | 2016-08-09 | 8,000 | 8,000 | Direct |
| Common Stock | Stock option (right to buy) | $12.69 | 2008-08-13 | 2017-08-08 | 8,000 | 8,000 | Direct |
| Common Stock | Stock Option (right to buy) | $18.63 | 2009-08-12 | 2018-08-13 | 13,500 | 13,500 | Direct |
| Common Stock | Stock Option (right to buy) | $7.67 | 2010-08-11 | 2019-08-12 | 13,500 | 13,500 | Direct |
| Common Stock | Stock Option (right to buy) | $9.99 | 2011-08-10 | 2020-08-11 | 13,500 | 13,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2016-08-09 | 8,000 | 8,000 | Direct |
| 2017-08-08 | 8,000 | 8,000 | Direct |
| 2018-08-13 | 13,500 | 13,500 | Direct |
| 2019-08-12 | 13,500 | 13,500 | Direct |
| 2020-08-11 | 13,500 | 13,500 | Direct |
Footnotes
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.5000 and $70.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.5000 and $71.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.5200 and $72.3900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.5300 and $73.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $73.5300 and $73.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This option becomes exerciseable in full on the date set forth in Table II, Column 6.
Billionaire Hedge Funds
